Gene · 28695
Papers3,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells. | Mol Ther Methods Clin Dev | 2023 | 37822720 | PubTator, text mining | PubMed |
| Mucosal-associated invariant T cells display both pathogenic and protective roles in patients with inflammatory bowel diseases. | Amino Acids | 2023 | 37819474 | PubTator, text mining | PubMed |
| Evolution by innovation as a driving force to improve TCR-T therapies. | Front Oncol | 2023 | 37810959 | PubTator, text mining | PubMed |
| Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design. | iScience | 2023 | 37810241 | PubTator, text mining | PubMed |
| Translatomics to explore dynamic differences in immunocytes in the tumor microenvironment. | Mol Ther Nucleic Acids | 2023 | 37808922 | PubTator, text mining | PubMed |
| Macroevolution of avian T cell receptor C segments using genomic data. | Immunogenetics | 2023 | 37804321 | PubTator, text mining | PubMed |
| Allosteric inhibition of the T cell receptor by a designed membrane ligand. | Elife | 2023 | 37796108 | PubTator, text mining | PubMed |
| Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial. | Clin Cancer Res | 2023 | 37792433 | PubTator, text mining | PubMed |
| Molecular Mechanisms of DNA Sequence Selectivity in V(D)J Recombination. | ACS Omega | 2023 | 37779976 | PubTator, text mining | PubMed |
| Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses. | Cell Rep Methods | 2023 | 37776855 | PubTator, text mining | PubMed |
| Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses. | Int J Mol Sci | 2023 | 37761976 | PubTator, text mining | PubMed |
| Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer. | NPJ Breast Cancer | 2023 | 37758711 | PubTator, text mining | PubMed |
| Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan. | Nat Immunol | 2023 | 37749325 | PubTator, text mining | PubMed |
| Genetically determined thymic function affects strength and duration of immune response in COVID patients with pneumonia. | Sci Adv | 2023 | 37738336 | PubTator, text mining | PubMed |
| Multimodal single-cell datasets characterize antigen-specific CD8+ T cells across SARS-CoV-2 vaccination and infection. | Nat Immunol | 2023 | 37735591 | PubTator, text mining | PubMed |
| Discovering immunoreceptor coupling and organization motifs. | Front Immunol | 2023 | 37731510 | PubTator, text mining | PubMed |
| Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. | Nat Commun | 2023 | 37730678 | PubTator, text mining | PubMed |
| PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma. | Nat Cancer | 2023 | 37723306 | PubTator, text mining | PubMed |
| αβ-T cell receptor transduction gives superior mitochondrial function to γδ-T cells with promising persistence. | iScience | 2023 | 37720098 | PubTator, text mining | PubMed |
| Genetic signature detected in T cell receptors from patients with severe COVID-19. | iScience | 2023 | 37720084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28695/papers?page=9